We’re challenge seekers. Get to know us and it’s plain to see—we’re powered by hope and innovation.
Our teams possess the grit, perseverance and diverse expertise required to address the most complex medical challenges. Here, each day is an opportunity to make a meaningful difference.
Our dedicated team members are committed to engaging, empowering and bringing hope to those suffering from complex and challenging conditions.
Part of enfolding the health of people around the world is identifying with them on a personal level. At MTPA, culture & belonging are integral components of our formula for innovation. The distinct experiences, backgrounds, and perspectives that each member of our team brings act as the catalyst for groundbreaking ideas and, subsequently, create hope for those who must face illnesses head-on. By fostering a culture of belonging we enhance problem-solving, expand our customer base, and address unmet needs more effectively. Cultivating a sense of belonging isn’t just beneficial for our bottom line—it’s better for humanity.
Company Snapshot
+350
Full-time employees across USA
+300
Years of innovation
Headquartered in Jersey City, NJ
When you join MTPA, you’ll join a team dedicated to making a real difference in people’s lives.
Registration of Clinical Trial Information and Disclosure of Results
a. Registration of our clinical trial information, and disclosure of results, to clinical trial registries
MTPA will register and disclose information on publicly accessible clinical trial registries such as ClinicalTrials.gov regarding clinical trials that are being conducted or have been conducted.
b. Disclosure of clinical trial summary results
MTPA will disclose the results from clinical trials in patients that form part of the submission package for products approved in the United States. Results will not be disclosed if MTPA decides that disclosure may lead to identification of clinical trial participants. Results may not be disclosed under any of the following conditions:
- A third party, such as a company involved in joint development, has not agreed to disclosure.
- Disclosure may interfere with publication in medical journals.
- Disclosure may interfere with the protection of intellectual property rights.